S G Nair1, S A Golden, Y Shaham. 1. Behavioral Neuroscience Branch, NIDA/IRP/NIH/DHHS, Baltimore, MD 21224, USA.
Abstract
BACKGROUND AND PURPOSE: Many studies have demonstrated a role of hypocretin 1 (orexin 1) receptors in home-cage food consumption in rodents. However, the role of these receptors in operant food self-administration or relapse to food seeking in animal models is unknown. EXPERIMENTAL APPROACH: In Experiment 1, we trained food-restricted rats (16-20 g per day) to lever press for high-fat (35%) pellets (3-6 h per day, every other day). We then tested the effect of the hypocretin 1 receptor antagonist SB 334867 (10, 20 mg kg(-1), i.p) on pellet self-administration. In Experiment 2, we trained rats to self-administer the food pellets, and following extinction of the food-reinforced responding, we tested the effect of hypocretin 1 (3 and 6 mug, i.c.v) on reinstatement of food-seeking and the effect of SB 334867 on this reinstatement. In Experiment 3, we tested the effect of SB 334867 on reinstatement induced by non-contingent pellet exposure (pellet-priming) or the pharmacological stressor yohimbine (2 mg kg(-1), i.p). KEY RESULTS: SB 334867 attenuated high-fat pellet self-administration. In contrast, SB 334867 had no effect on reinstatement of lever presses induced by hypocretin 1, pellet-priming or yohimbine. CONCLUSIONS AND IMPLICATIONS: These data indicate that during dieting, hypocretin 1 receptors contribute to operant high-fat pellet self-administration, but not to relapse to food seeking induced by acute re-exposure to the food itself or by the induction of a stress-like state.
BACKGROUND AND PURPOSE: Many studies have demonstrated a role of hypocretin 1 (orexin 1) receptors in home-cage food consumption in rodents. However, the role of these receptors in operant food self-administration or relapse to food seeking in animal models is unknown. EXPERIMENTAL APPROACH: In Experiment 1, we trained food-restricted rats (16-20 g per day) to lever press for high-fat (35%) pellets (3-6 h per day, every other day). We then tested the effect of the hypocretin 1 receptor antagonist SB 334867 (10, 20 mg kg(-1), i.p) on pellet self-administration. In Experiment 2, we trained rats to self-administer the food pellets, and following extinction of the food-reinforced responding, we tested the effect of hypocretin 1 (3 and 6 mug, i.c.v) on reinstatement of food-seeking and the effect of SB 334867 on this reinstatement. In Experiment 3, we tested the effect of SB 334867 on reinstatement induced by non-contingent pellet exposure (pellet-priming) or the pharmacological stressor yohimbine (2 mg kg(-1), i.p). KEY RESULTS:SB 334867 attenuated high-fat pellet self-administration. In contrast, SB 334867 had no effect on reinstatement of lever presses induced by hypocretin 1, pellet-priming or yohimbine. CONCLUSIONS AND IMPLICATIONS: These data indicate that during dieting, hypocretin 1 receptors contribute to operant high-fat pellet self-administration, but not to relapse to food seeking induced by acute re-exposure to the food itself or by the induction of a stress-like state.
Authors: Udi E Ghitza; Sarah M Gray; David H Epstein; Kenner C Rice; Yavin Shaham Journal: Neuropsychopharmacology Date: 2005-12-07 Impact factor: 7.853
Authors: T J De Vries; Y Shaham; J R Homberg; H Crombag; K Schuurman; J Dieben; L J Vanderschuren; A N Schoffelmeer Journal: Nat Med Date: 2001-10 Impact factor: 53.440
Authors: D Smart; J C Jerman; S J Brough; S L Rushton; P R Murdock; F Jewitt; N A Elshourbagy; C E Ellis; D N Middlemiss; F Brown Journal: Br J Pharmacol Date: 1999-09 Impact factor: 8.739
Authors: R J Rodgers; J C Halford; R L Nunes de Souza; A L Canto de Souza; D C Piper; J R Arch; N Upton; R A Porter; A Johns; J E Blundell Journal: Eur J Neurosci Date: 2001-04 Impact factor: 3.386
Authors: Andrea C Haynes; Helen Chapman; Colleen Taylor; Gary B T Moore; Michael A Cawthorne; Mohammad Tadayyon; John C Clapham; Jonathan R S Arch Journal: Regul Pept Date: 2002-03-15
Authors: Thorfinn T Riday; Eric W Fish; J Elliott Robinson; Thomas M Jarrett; Megan M McGuigan; C J Malanga Journal: Brain Res Date: 2011-11-07 Impact factor: 3.252
Authors: Carlo Cifani; Eisuke Koya; Brittany M Navarre; Donna J Calu; Michael H Baumann; Nathan J Marchant; Qing-Rong Liu; Thi Khuc; James Pickel; Carl R Lupica; Yavin Shaham; Bruce T Hope Journal: J Neurosci Date: 2012-06-20 Impact factor: 6.167
Authors: Mark G LeSage; Jennifer L Perry; Catherine M Kotz; David Shelley; William A Corrigall Journal: Psychopharmacology (Berl) Date: 2010-02-24 Impact factor: 4.530
Authors: James R Shoblock; Natalie Welty; Leah Aluisio; Ian Fraser; S Timothy Motley; Kirsten Morton; James Palmer; Pascal Bonaventure; Nicholas I Carruthers; Timothy W Lovenberg; Jamin Boggs; Ruggero Galici Journal: Psychopharmacology (Berl) Date: 2010-12-22 Impact factor: 4.530
Authors: Angie M Cason; Rachel J Smith; Pouya Tahsili-Fahadan; David E Moorman; Gregory C Sartor; Gary Aston-Jones Journal: Physiol Behav Date: 2010-03-23
Authors: Jonathan A Hollander; Qun Lu; Michael D Cameron; Theodore M Kamenecka; Paul J Kenny Journal: Proc Natl Acad Sci U S A Date: 2008-11-24 Impact factor: 11.205